Cellyan Biotechnology Co., Ltd (HKPD) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Cellyan Biotechnology Co., Ltd (HKPD) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $5.9M, listed on NASDAQ, employing roughly 27 people, carrying a beta of 2.63 to the broader market. Cellyan Biotechnology Co. Led by Chenyu Liang, public since 2025-01-15.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for HKPD as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →